The label for Novo Nordisk’s weight loss drug Ozempic now acknowledges some users’ reports of ileus, or intestinal blockage. In its update, however, the FDA said it’s difficult to confirm a causal ...
The label for the diabetes drug Ozempic — which has become popular for weight loss — now acknowledges reports of blocked intestines following use of the medication. The change comes after the Food and ...
Following the Trump administration's plans to explore whether a widely available generic medication called leucovorin could cure autism, GSK (NYSE:GSK), which once manufactured and marketed the ...
In the face of tough competition from Apellis and a recent setback with prescribers, Astellas’ geographic atrophy (GA) med Izervay has nabbed a much-needed label update from the FDA. The agency lifted ...
Vyjuvek (beremagene geperpavec-svdt) is the first topical gene therapy approved to heal wounds in adults and children with dystrophic epidermolysis bullosa (DEB). DEB is a rare genetic skin condition ...
Wegovy® recommended by the European regulatory authorities for label update to reflect reduced heart failure symptoms and improved physical function Wegovy® (semaglutide 2.4 mg) is the first obesity ...
Please provide your email address to receive an email when new articles are posted on . The FDA has updated the label for Ozempic to include the potential risk for ileus, or an intestinal blockage, as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback